The Readout Loud

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Den här podcasten är hämtad från ett öppet RSS-flöde och publiceras inte av Podme. Den kan innehålla reklam.

Avsnitt(417)

319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides

319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides

It's a guest-free episode this week, giving Allison, Adam and Elaine ample time to chat about the management shakeup at BioMarin, including the announcement that James Sabry, the former Roche dealmake...

22 Aug 202434min

318: Drug pricing drops & psychedelics under fire

318: Drug pricing drops & psychedelics under fire

STAT’s chief Washington correspondent Rachel Cohrs Zhang joins us to discuss the discounts and how this first round of negotiations between pharmaceutical companies and Medicare officials played out. ...

15 Aug 202421min

317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision

317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision

STAT's Washington Correspondent John Wilkerson joins us to discuss the first round of drug pricing negotiations under the Inflation Reduction Act, which will wrap up by September 1. We also cover the ...

8 Aug 202428min

316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates

316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates

Andrew Joseph, STAT's Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world's first malaria vaccines. We also cover the latest news in the biotech i...

1 Aug 202434min

315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves

315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves

What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout ...

25 Juli 202432min

314: JD Vance's biotech ties, Cassava resignations, and insulin shortages

314: JD Vance's biotech ties, Cassava resignations, and insulin shortages

Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss...

18 Juli 202433min

313: Biotech layoffs, founder-focused VC, & a big pharma exit

313: Biotech layoffs, founder-focused VC, & a big pharma exit

STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotec...

11 Juli 202434min

312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

STAT health tech reporter Brittany Trang guest co-hosts "The Readout LOUD" this week, where we discuss AI for drug development, the latest in the H5N1 bird flu outbreak, a surprise entrant to the GLP-...

27 Juni 202428min

Populärt inom Business & ekonomi

framgangspodden
rss-jossan-nina
varvet
rss-borsens-finest
24fragor
uppgang-och-fall
svd-tech-brief
avanzapodden
badfluence
rss-inga-dumma-fragor-om-pengar
bathina-en-podcast
lastbilspodden
fill-or-kill
tabberaset
rss-dagen-med-di
kapitalet-en-podd-om-ekonomi
borsmorgon
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-kort-lang-analyspodden-fran-di
rss-hos-psykologen